Tacrolimus is a macrolide immunosuppressant derived from Streptomyces tsukubaensis. It binds to FK506-binding protein (FKBP) 12, a member of the immunophilin family, to produce many biological actions.1) Repeated topical application of tacrolimus is effective against pruritus of atopic dermatitis, 2,3) and the decrease of pruritus may be mainly due to the reduction of dermatitis and cytokine production.1) This view is supported by the finding that repeated topical application of tacrolimus suppresses increases in CD4 ϩ T cells, mast cells, eosinophils, interleukin-4, interleukin-5, and immunoglobulin E in the skin of mice with atopy-like chronic dermatitis. 4) In contrast, although repeated topical application of tacrolimus inhibits scratching in mice with allergic dermatitis, it does not suppress increases in lymphocytes, eosinophils, mast cells and messenger ribonucleic acid (mRNA) of interleukin-5 in the affected skin and serum concentration of immunoglobulin E.5) It suppresses increases in mRNA for interleukin-4 and interferon-g, which are also suppressed by glucocorticoid at a topical dose that does not affect scratching.5) Pruritus of primary biliary cirrhosis, a non-allergic and non-inflammatory disease, was reported to be inhibited by repeated topical application of tacrolimus to the areas affected by the pruritus. 6) These findings raise the possibility that immunosuppressive action is not an exclusive mechanism of the anti-pruritic effect of tacrolimus.Topical application of tacrolimus causes skin burning and pruritus to the application site in about a quarter of patients.
7)Tacrolimus produces the transient increase of discharge in cutaneous C-fibers in the skin-nerve preparation.
8)Tacrolimus also increases intracellular Ca 2ϩ concentration in a small population of sensory neurons in the primary culture and most of tacrolimus-sensitive neurons respond to capsaicin.8) Capsaicin-sensitive sensory nerves may be involved in signaling of itch as well as pain.9) These findings suggest that tacrolimus directly acts on the primary sensory nerve, some of which are involved in itch and pain signaling.It is possible that these acute actions of tacrolimus affect itch sensation. The present study was conducted to determine whether topical application of tacrolimus would produce an acute anti-pruritic effect.
MATERIALS AND METHODS
AnimalsMale ICR mice (Japan SLC, Shizuoka) of 5 weeks old at the start of experiments were used. They were housed six per cage under controlled temperature (22Ϯ1°C) and humidity (55Ϯ10%). The room was lighted from 7:00 a.m. to 7:00 p.m. Food and water were available ad libitum. The study was approved by the Committee for Animal Experiments at University of Toyama.Materials Histamine (Sigma, St. Louis, MO, U.S.A.), serotonin hydrochloride (Sigma), substance P (Peptide Institute, Osaka), and the protease-activated receptor-2 agonist SLIGRL-NH 2 , synthesized by LJ, were dissolved in saline. These compounds were injected intradermally in a volume of 50 ml into the rostral part of the mouse ...